Home › Ariad receives nod to resume US sales of leukemia drug
 

Keywords :   


Ariad receives nod to resume US sales of leukemia drug

2013-12-21 12:09:24| Biotech - Topix.net

Seven weeks after Ariad Pharmaceuticals Inc. was forced to halt US sales of its leukemia drug, prompting an outcry from patients and doctors, the Food and Drug Administration issued new safety measures Friday that will allow the Cambridge biotech to resume selling the medicine.

Tags: sales drug resume receives

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
03.07Hurricane Beryl Graphics
03.07Hurricane Beryl Forecast Discussion Number 19
03.07Hurricane Beryl Wind Speed Probabilities Number 19
03.07Hurricane Beryl Public Advisory Number 19
03.07Summary for Hurricane Beryl (AT2/AL022024)
03.07Hurricane Beryl Forecast Advisory Number 19
03.07Hurricane Beryl Graphics
03.07Hurricane Beryl Public Advisory Number 18A
More »